CBD and Cannabis News Update

Regulators warn ex-football pro to stop marketing CBD as a cure for COVID-19.

April 06, 2020

ALEXANDRIA, Va.—NACS publishes periodic roundups of news and information on cannabis and CBD to help update Daily readers on the fast-moving products and their legality. Here are the topics in the news for the week of April 5-11, as the CBD and cannabis industry responds to the coronavirus pandemic.

U.S. Federal Activity

  • Feds Tell Ex-NFL Star to Stop Saying His Marijuana Can Cure Coronavirus. The Federal Trade Commission and the Food and Drug Administration sent a warning letter to the Las Vegas headquarters of Neuro XPF, which is owned by former NFL offensive tackle Kyle Turley, demanding the company stop marketing its cannabidiol (CBD) products as a cure for the coronavirus disease 2019 (COVID-19). (Source: Daily Beast)
  • CBD Buyers Say They Shouldn't Have to Wait for FDA Action. Consumers shouldn’t have to wait for the U.S. Food and Drug Administration to release further guidance on how it will regulate CBD products before they can sue over illegal products on store shelves now, a proposed class of customers told a California federal judge on Friday. (Source: Law360)
  • Senate Coalition Asks Congress to Allow SBA to Support Small Cannabis Businesses. Eleven U.S. Senators—Michael Bennett (D-CO), Cory Booker (D-NJ), Tammy Duckworth (D-IL), Kirsten Gillibrand (D-NY), Kamala Harris (D-CA), Edward Markey (D-MA), Robert Menendez (D-NJ), Jeffrey Merkley (D-OR), Jacky Rosen (D-NV), Bernie Sanders (I/D-VT) and Ron Wyden (D-OR)—have sent a letter to Senate leadership urging lawmakers to permit licensed cannabis operators to qualify for loans and other forms economic assistance available from the Small Business Administration. (Source: NORML)
State And Local Activity
  • Florida Judge: FDA’s CBD Review Shouldn’t Stop Labeling Claims. Ongoing review of cannabidiol (CBD) by the U.S. Food and Drug Administration shouldn’t mean that CBD makers are protected from facing labeling lawsuits, a federal judge in Florida ruled. (Source: Hemp Industry Daily)
  • Recreational Marijuana Could Add $100 Million to Oklahoma's Virus-Shattered Budget, Lawmaker Says of New Proposal. An Oklahoma lawmaker confirmed he will begin work on a bill that would allow adult use of recreational cannabis, saying the idea is "worth exploring," especially in light of sustained economic downturn during the COVID-19 emergency. (Source: Tulsa World)
  • New York: Some Ideas Live, Some—Including Legalized Pot—Won't Survive New State Budget. With a new state budget due before the clock turned to April 1, some budget bills began making their public appearance on Tuesday, making it apparent that the legalization of marijuana for recreational use will not happen in New York in 2020. (Source: The Buffalo News)
  • Virus Will Likely Doom Effort to Put Marijuana Legalization on Missouri Ballot. With the coronavirus pandemic prompting business shutdowns and stay-at-home orders, backers of a campaign to fully legalize marijuana in Missouri will likely put their plans on hold. (Source: St. Louis Post-Dispatch)
  • Wisconsin: CBD Stores Nonessential Under “Safer At Home” Order, Deliveries Still Allowed. Cannabidiol (CBD) store owners say they're confused by contradicting stay-at-home orders in Wisconsin. The state says CBD stores are not considered essential businesses, but the City of Milwaukee's order says otherwise. (Source: WTMJ
  • Idaho Activists Suspend Campaign to Legalize Medical Marijuana Due to Coronavirus. The Idaho Cannabis Coalition said that volunteers will no longer be conducting in-person signature gathering, and that will likely leave the campaign without enough signatures to make the ballot. They had to collect 55,057 by May 1 to qualify. What that means is “the odds are against Idahoans being able to vote on medical marijuana in November of 2020,” campaign spokesperson Russ Belville told Marijuana Moment in an email. (Source: Marijuana Moment)
Miscellaneous 
  • SF Marijuana Dispensaries See Big Shift to Edibles Amid Coronavirus. While customers are purchasing with regularity, their buying habits may be changing, at least in the short term. Cannabis delivery company Eaze said that since March 9, the company has seen sales of edibles rise from 15% to 30%, while the sale of the plant itself has decreased from 25% to 17%. (Source: SFGate)
NACS has prepared a fact sheet (for members only) to help you navigate what’s legal and what’s not for CBD retailing.
Advertisement
Advertisement
Advertisement